Verve Therapeutics
VERV
#6848
Rank
โ‚ฌ0.40 B
Marketcap
4,59ย โ‚ฌ
Share price
9.83%
Change (1 day)
-29.25%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -3,00ย โ‚ฌ

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -2,77ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,55ย โ‚ฌ a decrease over its 2021 EPS that were of -2,21ย โ‚ฌ.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-3,00ย โ‚ฌ17.56%
2022-2,55ย โ‚ฌ15.54%
2021-2,21ย โ‚ฌ61.32%
2020-1,37ย โ‚ฌ